Skip to Main Content

Paper Details

The E3 ligase TRIM1 ubiquitinates LRRK2 and controls its localization, degradation, and toxicity.
J Cell Biol
9
2022
-, 14-3-3, 981, E3 ligase, E3 ubiquitin ligase, LRRK2, LRRK2 RL, LRRK2 kinase, LRRK2853, LRRK2911-919, PD, Rab29, Ser910, Ser935, TRIM1, amino acid, cytoplasmic, familial Parkinson's disease, leucine, leucine-rich repeat kinase 2, mutant LRRK2 G2019S, neurite, tripartite motif family 1
Cytoskeleton, Humans, Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, Microtubule-Associated Proteins, Microtubules, Mutation, Parkinson Disease, Phosphorylation, Protein Serine-Threonine Kinases, Transcription Factors, Tripartite Motif Proteins, Ubiquitin-Protein Ligases, Ubiquitination, rab GTP-Binding Proteins
Author NameAffiliation
Adrienne E D StormoUniversity of California San Francisco
Farbod ShavarebiUniversity of California San Diego
Molly FitzGibbonUniversity of California San Diego
Elizabeth M EarleyUniversity of California San Francisco
Hannah AhrendtUniversity of California San Diego
Lotus S LumUniversity of California San Francisco
Erik VerschuerenUniversity of California San Francisco
Erik VerschuerenQuantitative Biosciences Institute, University of California San Francisco
Danielle L SwaneyUniversity of California San Francisco
Danielle L SwaneyQuantitative Biosciences Institute, University of California San Francisco
Gaia SkibinskiTaube/Koret Center for Neurodegenerative Disease Research, J. David Gladstone Institutes
Gaia SkibinskiCenter for Systems and Therapeutics, J. David Gladstone Institutes
Abinaya RavisankarTaube/Koret Center for Neurodegenerative Disease Research, J. David Gladstone Institutes
Abinaya RavisankarCenter for Systems and Therapeutics, J. David Gladstone Institutes
Jeffrey van HarenUniversity of California San Francisco
Jeffrey van Haren
Emily J DavisUniversity of California San Francisco
Jeffrey R JohnsonUniversity of California San Francisco
Jeffrey R JohnsonQuantitative Biosciences Institute, University of California San Francisco
John Von DollenUniversity of California San Francisco
John Von DollenQuantitative Biosciences Institute, University of California San Francisco
Carson BalenUniversity of California San Diego
Jacob PorathUniversity of California San Diego
Claudia CrosioUniversity of Sassari
Christian MirescuMerck & Co. Inc.
Ciro IaccarinoUniversity of Sassari
William T DauerUniversity of Texas Southwestern Medical Center
William T DauerUniversity of Texas Southwestern Medical Center
William T DauerPeter O'Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center
Robert J NicholsStanford University
Torsten WittmannUniversity of California San Francisco
Timothy C CoxUniversity of Missouri Kansas City
Timothy C CoxUniversity of Missouri Kansas City
Steven FinkbeinerUniversity of California San Francisco
Steven FinkbeinerCenter for Systems and Therapeutics, J. David Gladstone Institutes
Steven FinkbeinerTaube/Koret Center for Neurodegenerative Disease Research, J. David Gladstone Institutes
Steven FinkbeinerUniversity of California San Francisco
Steven FinkbeinerUniversity of California San Francisco
Steven FinkbeinerUniversity of California San Francisco
Steven FinkbeinerTaube/Koret Center for Neurodegenerative Disease Research, J. David Gladstone Institutes
Steven FinkbeinerCenter for Systems and Therapeutics, J. David Gladstone Institutes
Nevan J Krogan (CM4AI)University of California San Francisco
Nevan J Krogan (CM4AI)Quantitative Biosciences Institute, University of California San Francisco
Nevan J Krogan (CM4AI)Center for Systems and Therapeutics, J. David Gladstone Institutes
Scott A OakesUniversity of California San Francisco
Scott A OakesUniversity of Chicago
Annie HinikerUniversity of California San Diego
  • 1 - 47

Datasets